Journal
DRUG DISCOVERY TODAY
Volume 27, Issue 10, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2022.07.007
Keywords
Alzheimer's disease; Drug discovery; Multi-target directed ligands; Nitrogen heterocycles
Categories
Funding
- Department of Defense [W81XWH210053]
Ask authors/readers for more resources
Alzheimer's disease is a progressive neurodegenerative disease with limited clinical options. Research is ongoing to find effective anti-AD compounds, and this review explores previous strategies, research findings, and success stories. Strategies for designing and developing small molecules for AD treatment are also proposed.
Alzheimer's disease (AD) is a detrimental neurodegenerative disease that progressively worsens with time. Clinical options are limited and only provide symptomatic relief to AD patients. The search for effective anti-AD compounds is ongoing with a few already in Phase III clinical trials, yet to be approved. Heterocycles containing nitrogen are important to biological processes owing to their abundance in nature, their function as subunits of biological molecules and/or macromolecular structures, and their biological activities. The present review discusses previously used strategies, SAR, relevant in vitro and in vivo studies, and success stories of nitrogen-containing heterocyclic compounds in AD drug discovery. Also, we propose strategies for designing and developing novel potent anti-AD small molecules that can be used as treatments for AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available